Black Diamond Therapeutics rakes in $85 mln Series C
Cambridge, Massachusetts-based Black Diamond Therapeutics, Inc., a precision oncology medicine company, has raised $85 million in Series C financing.
Cambridge, Massachusetts-based Black Diamond Therapeutics, Inc., a precision oncology medicine company, has raised $85 million in Series C financing.
Copyright PEI Media
Not for publication, email or dissemination